HM
OSRH

Howard Marks’s OSR Health OSRH Stock Holding History

Howard Marks’s Portfolio OSRH Stock Details OSRH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-175,000
Closed -$1.8M – 211
2023
Q2 		$1.8M Hold
175,000
– – 0.02% 203
2023
Q1 		$1.77M Buy
+175,000
New +$1.77M 0.02% 250

Other funds holding OSRH

PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return

Howard Marks's OSRH Position: Q3 2023 in Review

Howard Marks sold out of OSR Health (OSRH) in Q3 2023, closing a stake of 175,000 shares — an estimated $1.8M sold.

Howard Marks first reported a position in OSRH in Q1 2023 and held it in 2 quarters. The position peaked at $1.8M in Q2 2023. 37 funds tracked by Wall St. Rank hold OSRH as of Q3 2023.

  • Howard Marks reported no remaining OSR Health position as of Q3 2023 after selling out during the quarter.
  • Howard Marks sold 175,000 OSR Health shares in Q3 2023, an estimated $1.8M.
  • Howard Marks first reported a position in OSR Health in Q1 2023 and held it in 2 quarters.
  • Howard Marks's OSR Health position peaked at $1.8M in Q2 2023.
  • 37 funds tracked by Wall St. Rank held OSR Health as of Q3 2023.

Based on Oaktree Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.